暂无标题

ZHU Weiwei; GUO Chenyu; ZHANG Lei; LI Kangqi; WANG Jing; SUN Yongxu; LU Congxiao

您当前的位置：

首页 >

文章列表页 >

暂无标题

更新时间：2023-03-01

- 暂无标题
- China Pharmacy Vol. 27, Issue 14, (2016)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2016，
扫描看全文
ZHU Weiwei, GUO Chenyu, ZHANG Lei, et al. [J]. China Pharmacy 27(14).(2016)
DOI：

ZHU Weiwei, GUO Chenyu, ZHANG Lei, et al. [J]. China Pharmacy 27(14).(2016) DOI：

摘要

目的：分析细胞色素P450酶（CYP）3A5（6986A＞G）基因多态性与多西他赛不良反应（ADR）之间的相关性，为减少多西他赛所致ADR提供有效建议。方法：采用前瞻性队列研究，用焦磷酸测序的方法检测患者的CYP3A5（6986A＞G）基因型，建立显性遗传模型，并使用SPSS 20.0评估基因型与该药所致ADR之间的相关性。结果：共纳入117例患者，其中野生型（AA）3例、突变杂合型（AG）30例、突变纯合型（GG）84例。显性遗传模型的统计分析结果显示，CYP3A5（6986A＞G） GG组的周围神经毒性和指/趾甲毒性发生率显著高于（AA+AG）组，差异有统计学意义（P＜0.05）。结论：CYP3A5（6986A＞G）GG基因型显著增加了多西他赛所致周围神经毒性和指/趾甲毒性的发生风险。

Abstract

OBJECTIVE： To analyze the correlation between CYP3A5（6986A＞G） gene polymorphism and ADRs caused by docetaxel in order to provide suggestions for reducing the ADR caused by docetaxel. METHODS： In prospective cohort study， pyrosequencing was adopted to detect CYP3A5 genotype （6986A＞G）. Dominant genetic model was established， and the correlation between genotype and ADR caused by docetaxel was evaluated by SPSS 20.0. RESULTS： 117 patients were included. Among them， the number of wild type （AA）， mutation heterozygous type （AG）， mutation homozygous type （GG） was 3， 30 and 84 respectively. Dominant genetic model showed that the incidence of peripheral neurotoxicity and finger/toe nail toxicity in group GG was significantly higher than that of （AA+AG） group， with statistical significance（P＜0.05）. CONCLUSIONS： CYP3A5 （6986A＞G）GG genotype significantly increase the incidence of peripheral neurotoxicity and finger/toe nail toxicity caused by docetaxel.

关键词

细胞色素P450酶3A5基因多态性多西他赛不良反应

Keywords

CYP3A5Gene polymorphismDocetaxelADR

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

海南省汉族人群HLA-B*5801基因多态性与别嘌醇所致不良反应的相关性研究

自身免疫性疾病患者CYP3A4、CYP2C8和CYP3A5基因多态性与羟氯喹不良反应/血药浓度的相关性研究

骨肉瘤患者3种基因多态性与大剂量甲氨蝶呤不良反应相关性的Meta分析

Participation of clinical pharmacists in pharmaceutical care for a patient with Mycobacterium abscess infection after the resection of intervertebral schwannoma

我院免疫抑制剂超说明书用药情况分析

Related Author

YUN Xiong

WU Danna

HAN Fangxuan

HUANG Chunxin

PENG Wenxing

GAO Beibei

PAN Menglu

YANG Chunlan

Related Institution

Dept. of Pharmacy， Second Affiliated Hospital， Army Medical University

Dept. of Pharmacy， Chongqing Health Center for Women and Children/Women and Children’s Hospital of Chongqing Medical University

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

暂无标题

DOI：

摘要

Abstract

关键词

Keywords

references